BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29118397)

  • 1. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
    Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
    Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
    Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
    J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
    Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
    J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.
    Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC
    J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
    Parr C; Jiang WG
    Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis.
    Ko CJ; Hsu TW; Wu SR; Lan SW; Hsiao TF; Lin HY; Lin HH; Tu HF; Lee CF; Huang CC; Chen MM; Hsiao PW; Huang HP; Lee MS
    Oncogene; 2020 Sep; 39(37):5950-5963. PubMed ID: 32778768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
    Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
    Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
    Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
    J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
    Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
    Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.
    Tsai CH; Teng CH; Tu YT; Cheng TS; Wu SR; Ko CJ; Shyu HY; Lan SW; Huang HP; Tzeng SF; Johnson MD; Lin CY; Hsiao PW; Lee MS
    Oncogene; 2014 Sep; 33(38):4643-52. PubMed ID: 24121274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2.
    Maurer E; Gütschow M; Stirnberg M
    Biochem J; 2013 Mar; 450(3):583-93. PubMed ID: 23293962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase.
    Nonboe AW; Krigslund O; Soendergaard C; Skovbjerg S; Friis S; Andersen MN; Ellis V; Kawaguchi M; Kataoka H; Bugge TH; Vogel LK
    Traffic; 2017 Jun; 18(6):378-391. PubMed ID: 28371047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatocyte growth factor regulatory factors in human breast cancer.
    Parr C; Watkins G; Mansel RE; Jiang WG
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):202-11. PubMed ID: 14734471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease.
    Oberst MD; Chen LY; Kiyomiya K; Williams CA; Lee MS; Johnson MD; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2005 Aug; 289(2):C462-70. PubMed ID: 15800053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator.
    Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
    Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
    Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant regulation favours matriptase proteolysis in neoplastic B-cells that co-express HAI-2.
    Chiu YL; Wu YY; Barndt RB; Yeo YH; Lin YW; Sytwo HP; Liu HC; Xu Y; Jia B; Wang JK; Johnson MD; Lin CY
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):692-702. PubMed ID: 30777474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.
    Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H
    Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.